SEARCH BY TOPIC:

Find the content you are looking for on Diabetech by searching the desired device, company, or topic.

ŌURA and Tidepool Join Forces to Advance Diabetes Research

Nov 4, 2025

•

3 min read

ŌURA and Tidepool Join Forces to Advance Diabetes Research

The collaboration will link wearable, sleep, and menstrual cycle data with glucose trends to close long-standing gaps in women’s health and diabetes research.

Itzel Estrada

How RenewRx Aims to Rebuild Diabetes Management During Pregnancy

Nov 3, 2025

•

2 min read

How RenewRx Aims to Rebuild Diabetes Management During Pregnancy

RenewRx aims to fill the gaps left by the healthcare system to support providers and mothers manage gestational, type 1, and type 2 diabetes.

Team Diabetech

The Future of CGM Tech: Implantables, Brainwaves, and Beyond

Oct 31, 2025

•

3 min read

The Future of CGM Tech: Implantables, Brainwaves, and Beyond

A new generation of glucose monitors are in development — from long-term implantables to non-invasive sensors — promising faster, more seamless diabetes management.

Diabetech Justin

Tandem’s t:slim X2 Pump Officially Integrates the FreeStyle Libre 3 Plus CGM in the U.S.

Oct 29, 2025

•

3 min read

Tandem’s t:slim X2 Pump Officially Integrates the FreeStyle Libre 3 Plus CGM in the U.S.

All U.S. t:slim X2 users have access to FreeStyle Libre 3 Plus CGM integration, with international early-access programs rolling out later this year.

Diabetech Justin

California Caps Monthly Insulin at $35 and Launches $11 CalRx Insulin Pens to Tackle Drug Costs

Oct 29, 2025

•

2 min read

California Caps Monthly Insulin at $35 and Launches $11 CalRx Insulin Pens to Tackle Drug Costs

New laws and state-run manufacturing aim to make insulin more affordable to all Californians starting in 2026, setting a national example for diabetes care reform.

Itzel Estrada

Dexcom Faces Class Action After G7 CGM Recall and Alert Failures

Oct 28, 2025

•

3 min read

Dexcom Faces Class Action After G7 CGM Recall and Alert Failures

A California parent says Dexcom’s G7 continuous glucose monitor gave false readings and missed life-saving alerts, sparking a class action and renewed concerns over CGM safety.

Itzel Estrada